Mechanism IFNAR agonists [+5] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date04 Jun 2004 |
Mechanism IFNAR agonists [+5] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CA |
First Approval Date13 Aug 2002 |
Mechanism IFNAR agonists [+5] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date14 Jun 1998 |
Start Date06 Jan 2024 |
Sponsor / Collaborator |
Start Date08 Jan 2022 |
Sponsor / Collaborator |
Start Date30 Dec 2018 |
Sponsor / Collaborator |